CD4 and HIV infectious disease: As CRISPR mediated abrogation of CCR5 co-receptor gene conferred resistance to CD4 T cells for HIV infection, similar approach can be adopted to make the host cell resistant to SARS-CoV-2 by delivering the CRISPR-Cas13d into the susceptible host cells.